Anemia, Heart Failure and Evidence-Based Clinical Management

作者：Pereira Camila Alves; Roscani Meliza Goi; Zanati Silmeia Garcia^*; Matsubara Beatriz Bojikian

来源：Arquivos Brasileiros de Cardiologia, 2013, 101(1): 87-92.

DOI：10.5935/abc.20130126

• Iron deficiency
• Inflamation
• Iron supplementation
• Chronic disease
• Cardiovascular disease

Anemia is a prevalent comorbidity and marker of a poorer prognosis in patients with heart failure (HF). Its clinical relevance, as well as its pathophysiology and the clinical management of these patients are important subjects in the specialized literature. In the present review, we describe the current concepts on the pathophysiology of anemia in HF, its diagnostic criteria, and the recommendations for iron supplementation. Also, we make a critical analysis of the major studies showing evidences on the benefits of this supplementation. The four main components of anemia are addressed: chronic disease, dilutional, "renal" and malabsorption. In patients with HF, the diagnostic criteria are the same as those used in the general population: serum ferritin levels lower than 30 mcg/L in patients without kidney diseases and lower than 100 mcg/L or serum ferritin levels between 100-299 mcg/L with transferring saturation lower than 20% in patients with chronic kidney diseases. Finally, the therapeutic possibilities for anemia in this specific patient population are discussed.

• 出版日期2013-7